턱관절균형의학회지 (Journal of TMJ Balancing Medicine)

턱관절균형의학회 (Association of TMJ Balancing Medicine)
권호 표지

네트워크 약리학 분석을 통한 뚜렛 증후군에 유용할 것으로 예측되는 한약 자원 탐색

Discovery of Herbal Medicine Resources through Network Pharmacology Analysis Predicted to Be Useful for Tourette Syndrome

  • Lee, Byoungho (Injoo Hospital of Korean Medicine) ;
  • Cho, Suin (School of Korean Medicine, Pusan National University)
  • 투고 : 2020.11.27
  • 심사 : 2020.12.16
  • 발행 : 2020.12.30
PDF 다운로드
⟨ 이전 논문 다음 논문 ⟩

초록

Objectives: Tourette syndrome (TS) is a disease that occurs evenly in many social classes. Despite the long experience of drug treatment, the preference is low due to various side effects. The aim of this study was to discover herbal medicine resources through network pharmacology analysis predicted to be useful for Tourette syndrome. Methods: We used Traditional Chinese Medicine Systems Pharmacology Database and Analysis Platform (TCMSP) to identify herbal medicines that can be used for TS by using network pharmacology research methods and to predict the mechanism of action. After evaluating compounds of each identified herb, molecular target proteins and mechanisms of action were analyzed, focusing on compounds that are likely to exhibit clinical activity in consideration of the pharmacokinetic parameters of these individual compounds. Results: Fifty nine ingredients such as atropine, veraguensin, and nuciferin among the compounds contained in 48 types of medicinal herbs such as Daturae Flos (洋金花), Salviae Radix (丹参), and Nelumbinis Plumula (蓮子心) act on the D(2) dopamine receptor, which is a protein involved in the development of TS. It has been found that atropine, veraguensin, and nuciferin are highly likely to exhibit activity by acting on the G protein-coupled receptor signaling pathway. Conclusions: It can be used in conjunction with non-invasive treatment means such as FCST Yinyang Balancing Appliance with herbal therapy to bring about a significant therapeutic effect, and it will be possible to develop a treatment that can replace drug therapy used in Western medicine.

키워드

참고문헌

  1. Sandor P. Gilles de la Tourette syndrome:A neuropsychiatric disorder. J Psychosom Res. 1993;37(3):211-226. Cited from Gilles de la Tourette G. Etude sur nerveus caracterisee par de 1'incoordination motrice accompagnee d'echolatie et de coprolalie. Arch Neurol. 1885;9:19-42, 158-200. https://doi.org/10.1016/0022-3999(93)90030-J
  2. Min SK, Shin DW, Noh KS. A clinical study on Tourette's disorder. Korean J Child & Adol Psychiatr. 1997;8:92-100.
  3. Comings DE, Himes JA, Comings BG. An epidemiological study of Tourette's syndrome in a single school district. J Clin Psychiatry. 1990;51:463-469.
  4. Robertson. Annotation:Gilles de la Tourette Syndromean update. J Child Psychol Psychiat. 1994;35(4):597-611. https://doi.org/10.1111/j.1469-7610.1994.tb01209.x
  5. Min SK, Lee H. A clinical study on Gilles de la Tourette syndrome in Korea. Br J Psychiatry. 1986;149:644-647. https://doi.org/10.1192/bjp.149.5.644
  6. Cavanna AE, Rickards H, Worrall R, Hoekstra PJ, Plessen KJ, Roessner V. From ipse dixit to evidence-based guidelines: on the optimal management of Tourette syndrome. Eur J Paediatr Neurol. 2012;16(3):310-311. https://doi.org/10.1016/j.ejpn.2012.01.010
  7. Huys D, Hardenacke K, Poppe P, Bartsch C, Baskin B, Kuhn J. Update on the role of antipsychotics in the treatment of Tourette syndrome. Neuropsychiatr Dis Treat. 2012;8:95-104. https://doi.org/10.2147/NDT.S12990
  8. Steeves T, McKinlay BD, Gorman D, Billinghurst L, Day L, Carroll A, et al. Canadian guidelines for the evidence-based treatment of tic disorders: behavioural therapy, deep brain stimulation, and transcranial magnetic stimulation. Can J Psychiatry. 2012;57(3):144-151. https://doi.org/10.1177/070674371205700303
  9. Dugosh K, Abraham A, Seymour B, McLoyd K, Chalk M, Festinger D. A systematic review on the use of psychosocial interventions in conjunction with medications for the treatment of opioid addiction. J Addict Med. 2016;10(2):91-101.
  10. Roh HW, Hong CH, Lim HK, Chang KJ, Kim H, Kim NR, et al. A 12-week multidomain intervention for late-life depression: a community-based randomized controlled trial. J Affect Disord. 2020;263:437-444. https://doi.org/10.1016/j.jad.2019.12.013
  11. Kim JH, Jo HG, Seol JU. Review of clinical studies on traditional Chinese Medicine for Tourette syndrome. J of Oriental Neuropsychiatry. 2017;28(4):303-318. https://doi.org/10.7231/JON.2017.28.4.303
  12. Jung H, Sung WY, Lee S, Son JH, Han SH. A clinical report of a patient with Tourett's disorder. J of Oriental Neuropsychiatry. 2003;14(2):213-218.
  13. Yu DG, Lee YJ. Tourette's disorder cases managed by Yinyang balancing appliance of FCST, a TMJ therapy for the balance of meridian and neurological system. TMJ Bal Med. 2012;2:17-19.
  14. Wang H. A new strategy for integrated urban water management in China: Sponge city. Sci China Technol Sci. 2018;61(3):317-329. https://doi.org/10.1007/s11431-017-9170-5
  15. Ru J, Li P, Wang J, Zhou W, Li B, Huang C, et al. TCMSP: a database of systems pharmacology for drug discovery from herbal medicines. J Cheminform. 2014;6:13. https://doi.org/10.1186/1758-2946-6-13
  16. Beck JM, Seo HK, Kwon YK. Review of network pharmacological approaches on Korean Medicine. J Physiol & Pathol Korean Med. 2016;30(6):419-425. https://doi.org/10.15188/kjopp.2016.12.30.6.419
  17. Xu X, Zhang W, Huang C, Li Y, Yu H, Wang Y, et al. A novel chemometric method for the prediction of human oral bioavailability. Int J Mol Sci. 2012;13:6964-6982. https://doi.org/10.3390/ijms13066964
  18. Tao W, Xu X, Wang X, Li B, Wang Y, Li Y, et al. Network pharmacology-based prediction of the active ingredients and potential targets of Chinese herbal Radix Curcumae formula for application to cardiovascular disease. J Ethnopharmacol. 2013;145:1-10. https://doi.org/10.1016/j.jep.2012.09.051
  19. Shapiro AK, Shapiro E. Treatment of Gilles de la Tourette's Syndrome with haloperidol. Br J Psychiatry. 1968;114:345-350. https://doi.org/10.1192/bjp.114.508.345
  20. Verdellen C, van de Griendt J, Hartmann A, Murphy T. European clinical guidelines for Tourette syndrome and other tic disorders. Part III: behavioural and psychosocial interventions. Eur Child Adolesc Psychiatry. 2011;20:197-207. https://doi.org/10.1007/s00787-011-0167-3
  21. Venditti S, Verdone L, Reale A, Vetriani V, Caserta M, Zampieri M. Molecules of silence: Effects of meditation on gene expression and epigenetics. Front Psychol. 2020;11:1767. doi: 10.3389/fpsyg.2020.01767.
  22. Cotman CW, Berchtold. Exercise: a behavioral intervention to enhance brain health and plasticity. Trends Neurosci. 2002;25(6):295-301. https://doi.org/10.1016/S0166-2236(02)02143-4
  23. Yael D, Israelashvili M, Bar-Gad I. Animal models of Tourette syn-drome-from proliferation to standardization. Front Neurosci. 2016;10:132.
  24. Kenunen OG, Shchelkunov EL. Changes in neurovegetative regulation in the Tourette syndrome (according to ECG findings). Zh Nevropatol Psikhiatr Im S S Korsakova. 1987;87(6):907-910.
  25. Paraga HC, Harris KM, Paraga KL, Balen GM, Cruz C. An overview of the treatment of Tourette's disorder and tics. J Child Adolesc Psychopharmacol. 2010;20(4):249-262. https://doi.org/10.1089/cap.2010.0027
  26. Roessner V, Schoenefeld K, Buse J, Bender S, Ehrlich S, Muchau A. Pharmacological treatment of tic disorders and Tourette Syndrome. Neuropharmacology. 2013;68:143-149. https://doi.org/10.1016/j.neuropharm.2012.05.043